Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

BACKGROUND: Several clinical studies have established the efficacy, safety, and tolerability of long-acting risperidone administered once every 2 weeks in patients with schizophrenia or schizoaffective disorder. This report evaluates preliminary efficacy, safety, tolerability, and pharmacokinetic da...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharabawi, Georges M, Gearhart, Natalie C, Lasser, Robert A, Mahmoud, Ramy A, Zhu, Young, Mannaert, Erik, Naessens, Ineke, Bossie, Cynthia A, Kujawa, Mary, Simpson, George M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803785/
https://www.ncbi.nlm.nih.gov/pubmed/17261186
http://dx.doi.org/10.1186/1744-859X-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803785/
https://www.ncbi.nlm.nih.gov/pubmed/17261186
http://dx.doi.org/10.1186/1744-859X-6-3

Ejemplares similares